Irbesartan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2226 publications
Thiolated chitosan/alginate/Emodin nanoparticles alleviate chronic kidney disease via gut microbiota regulation and intestinal barrier protection.
Journal: Microbiology spectrum
Published: March 31, 2026
Different Astragalus medicinal pairs improve diabetic nephropathy in mice by regulating lipid peroxidation through PTGS2
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: March 26, 2026
FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner.
Journal: bioRxiv : the preprint server for biology
Published: March 23, 2026
Landscape of diabetic kidney disease drug clinical trials in China (2013-2023): global implications for innovation and policy.
Journal: Renal failure
Published: February 22, 2026
Sequential Oxidizing-Reducing Degradation of Organic Micropollutants in Simulated Riverbank Filtration.
Journal: Environmental science & technology
Published: February 13, 2026
Multi-Residue Determination and Risk Assessment of EU-Relevant Pharmaceuticals, Pesticides, and UV-Filters in Drinking Water.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 29, 2026
Decoding the Neuroprotective Intervention of Angiotensin Receptor Blockers: A Multimodal Approach Using In Silico Network Pharmacology, Molecular Modeling, and In Vivo Validation of Key Markers.
Journal: ACS chemical neuroscience
Published: December 11, 2025
A systematic review of commencing full-dose antihypertensives in newly diagnosed hypertension.
Journal: Blood pressure
Published: December 06, 2025
Long-term risk of dementia with angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive patients: A 15-year follow-up using the 45 and Up Study.
Journal: GeroScience
Published: December 03, 2025
Adherence, Switches, and Drug Spending After Angiotensin Receptor Blocker Recalls and Shortages.
Journal: JAMA health forum
Published: November 26, 2025
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
Journal: Journal of comparative effectiveness research
Published: November 20, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension.
Journal: Open heart
Published: November 12, 2025
Last Updated: 04/28/2026